Skip to main content
Acta Crystallographica Section F: Structural Biology and Crystallization Communications logoLink to Acta Crystallographica Section F: Structural Biology and Crystallization Communications
. 2011 Jun 23;67(Pt 7):749–752. doi: 10.1107/S1744309111018811

The structure of LpxD from Pseudomonas aeruginosa at 1.3 Å resolution

John Badger a,*, Barbara Chie-Leon a, Cheyenne Logan a, Vandana Sridhar a, Banumathi Sankaran b, Peter H Zwart b, Vicki Nienaber a
PMCID: PMC3144788  PMID: 21795786

The crystal structure of the bacterial protein LpxD from P. aeruginosa was solved and refined at 1.3 Å resolution. The overall domain architecture and biological assembly are similar to those found in previously solved structures of LpxD from other species.

Keywords: bacterial proteins, biosynthesis pathways, LpxD, Pseudomonas aeruginosa

Abstract

LpxD is a bacterial protein that is part of the biosynthesis pathway of lipid A and is responsible for transferring 3-hydroxymyristic acid from the R-3-hydroxymyristoyl-acyl carrier protein to the 2-OH group of UDP-3-O-(3-hydroxymyristoyl) glucosamine. The crystal structure of LpxD from Pseudomonas aeruginosa has been determined at high resolution (1.3 Å). The crystal belonged to space group H3, with unit-cell parameters a = b = 106.19, c = 93.38 Å, and contained one molecule in the asymmetric unit. The structure was solved by molecular replacement using the known structure of LpxD from Escherichia coli (PDB entry 3eh0) as a search model and was refined to R work = 16.4% (R free = 18.5%) using 91 655 reflections. The final protein model includes 355 amino-acid residues (including 16 amino acids from a 20 amino-acid N-terminal His tag), one chloride ion and two ethylene glycol molecules.

1. Introduction

Bacterial resistance to antibiotics, in particular by Gram-negative bacteria, is a growing issue in the clinical setting, with no new agents having been introduced since the 1980s, when carbapenems and fluoroquinolones were first studied (Jacoby, 2005). One organism of particular interest is the Gram-negative bacterium Pseudomonas aeruginosa, which is known to cause common and potentially fatal hospital infections and is naturally resistant to a large number of antibiotics (Lockhart et al., 2007). Hence, effective therapeutic strategies that will overcome resistance to P. aeruginosa represent a growing unmet medical need. One such strategy is interference with the synthesis of the Gram-negative bacterial cell wall.

The cell wall of Gram-negative bacteria is made up of two mem­branes. The inner membrane is composed of phospholipid and the outer membrane is composed of phospholipid and lipopolysaccharide (LPS). The ampipathic outer membrane contributes to protection against antibiotics. This membrane is crucial for bacterial survival and is toxic. Specifically, when the LPS cell wall is injected into animals it causes severe sepsis, intravascular coagulation and multiple organ failure (Esmon, 2000). LPS is composed of three components: the O-­antigen, which is the surface-exposed linear polysaccharide com­posed of 50–100 repeating saccharide units, the core oligosaccharide, which most often contains a branched 3-deoxy-d-manno-oct-2-ulosonic acid (KDO), and lipid A, which is a phosphorylated glucos­amine disaccharide with multiple fatty acids attached via ester and amide bonds. It is the lipid A component that is primarily responsible for the macrophage-activating endotoxic activity of LPS (Raetz & Whitfield, 2002).

The first three enzymes responsible for Gram-negative bacterial cell-wall synthesis, LpxA, LpxC and LpxD, are all present as single copies and are essential for bacterial viability. These enzymes are conserved across class A, B and C pathogens and are potential drug targets for the treatment of P. aeruginosa and other Gram-negative infections (Raetz, 1990; Raetz & Whitfield, 2002). In P. aeruginosa LpxD catalyzes the third step in LPS biosynthesis, transferring a 3-­hydroxydecanoyl moiety from acyl carrier protein (ACP) to UDP-3-O-(3-hydroxydecanoyl) glucosamine. However, the length of the fatty acid involved in this reaction varies with species. While in P. aeruginosa the reaction begins with R-3-hydroxydecanoyl-ACP, the Escherichia coli enzyme is specific for the myristic acid form and the Chlamydia trachomatis enzyme is specific for the arachidic acid form. Crystal structures of both the E. coli and C. trachomatis LpxD proteins have been previously solved and are compared with the P. aeruginosa structure in this report.

2. Materials and methods

2.1. Cloning and expression

LpxD was amplified with an NdeI/XhoI restriction site from P. aeruginosa genomic DNA using the primers TATATACATA­TGAGTACCTTGTCCTACACC and TATATACTCGAGTCACG­CATCAGATGAAG. Clones were sequence-verified and positive clones were transformed into E. coli BL21 (DE3) cells.

2.2. Purification

Cells containing the target plasmid were grown at 310 K until the OD600 reached 0.6. The cells were induced with 1 mM IPTG at 298 K overnight, harvested and stored at 193 K. Cell pellets was lysed in 50 mM Tris pH 7.8, 500 mM NaCl, 10% glycerol and 20 mM imidazole (lysis buffer). The suspension was sonicated on ice for 1 min at 70% output. The clarified supernatant was loaded onto Ni2+-charged IMAC. Unbound protein was washed out with lysis buffer. The target protein was eluted using a linear gradient from 20 to 250 mM imidazole. Elution fractions containing target protein were further purified on a size-exclusion column in 10 mM Tris pH 8, 500 mM NaCl and 1 mM DTT. Monomeric LpxD was then concentrated to 15 mg ml−1.

2.3. Crystallization and data collection

The protein sample was incubated with 50 mM uridine diphos­phate-N-acetylglucosamine (UDP-GlcNac) on ice for 1 h. Crystals of P. aeruginosa LpxD including an N-terminal His6 tag were obtained using the hanging-drop vapor-diffusion method by mixing 2 µl 15 mg ml−1 protein solution (in 10 mM Tris–HCl pH 8.0 containing 1 mM DTT and 500 mM NaCl) with 2 µl 100 mM Tris pH 8.5, 1.5 M lithium sulfate at 293 K. Diffracting crystals appeared within 3–5 d and grew to ∼0.4 mm in length. Similar crystals were also obtained in the absence of UDP-GlcNac. Prior to data collection, crystals were transferred into a cryoprotectant solution consisting of 20%(v/v) ethylene glycol in crystallization buffer and then flash-frozen in liquid nitrogen.

Diffraction data were collected at a wavelength of 1.0 Å using an ADSC Q315 CCD detector array on beamline 5.0.2 at the Advanced Light Source, Berkeley, California, USA. The crystals diffracted to 1.3 Å resolution and were indexed in space group H3, with unit-cell parameters a = b = 106.19, c = 93.38 Å. A set of 300 consecutive images in 1° increments were measured.

2.4. Structure solution and refinement

Data were indexed, integrated, scaled and merged (Table 1) using the programs MOSFLM and SCALA from CCP4 (Winn et al., 2011). The structure was solved by molecular replacement with MOLREP (Vagin & Teplyakov, 2010) using the PDB entry for LpxD from E. coli (PDB entry 3eh0; Bartling & Raetz, 2009) as the search model. The solution was consistent with the expectation of one molecule in the crystal asymmetric unit. Interactive model refitting and molecular-graphics analysis were performed using the MIFit software (http://code.google.com/p/mifit/). Reciprocal-space refinement was per­formed using REFMAC5 (Murshudov et al., 2011). Model rebuilding consisted primarily of sequence adjustment to the P. aeruginosa species and retracing the N-terminal domain (amino acids 2–96), which differed from the search model to an extent that was not correctable by automated refinement. The final protein model (Table 1) contained 339 amino acids, corresponding to residues 2–340, in an unbroken chain trace. In addition, electron density for 16 amino acids from the 20-amino-acid N-terminal His tag was visible and was fitted. One chlorine ion was identified on the basis of a 7σ feature in an anomalous difference map, an excessively low temperature factor when the density was initially fitted as a water molecule and a location that was consistent with a positively charged environment. Two density features were fitted by ethylene glycol molecules and 446 ordered water sites were identified. The occupancies of water molecules were reduced to less than unity if the water sites were on special positions, to resolve conflicts with partially occupied side chains and, in a few cases, in order to represent highly elongated solvent-density features. The structure refinement used all available structure-factor data with the ‘mask’ bulk-solvent model and 5% of reflections reserved for cross-validation tests. Individual anisotropic temperature factors were introduced in the final stages of the refinement, resulting in parallel falls in R work and R free of ∼2%. In addition to visual inspection, model quality was continuously assessed during the refinement via an automated battery of tests implemented and collected via the MIFit refinement interface, which included checks on standard protein covalent geometry, flags for cis-peptides, checks on short van der Waals contacts, abnormal ϕ–ψ angles (Lovell et al., 2003) and abnormal side-chain rotamers and flags for significant difference density features overlapping the protein. The conformations of the three amino acids listed as lying outside the expected range in the ϕ–ψ plots defined by Kleywegt & Jones (1996) are supported by strong electron density.

Table 1. Crystal and refinement parameters for LpxD from P. aeruginosa .

Values in parentheses are for the highest resolution shell.

Data processing
 Wavelength (Å) 1.0
 Unit-cell parameters (Å) a = b = 106.19, c = 93.38
 Space group H3
 Resolution range (Å) 26.85–1.30
 No. of observations 873265
 No. of unique reflections 96539
 Data completeness (%) 99.9 (100)
Rmerge 0.078 (0.644)
Rp.i.m 0.027 (0.227)
 〈I/σ(I)〉 14.1 (3.2)
 Multiplicity 9.0 (8.9)
Refinement
 Resolution range (Å) 26.85–1.30
 No. of observations 91655
 No. of protein atoms 2661
 No. of ligand and water atoms 455
 Mean protein B factor (Å2) 14.05
Rwork 0.164
Rfree 0.185
 R.m.s.d. bond lengths (Å) 0.007
 R.m.s.d. bond angles (°) 1.171
 R.m.s.d. B factors (Å2)
  Main-chain bond-related 0.996
  Main-chain angle-related 1.538
  Side-chain bond-related 1.831
  Side-chain angle-related 2.842

3. Results and discussion

3.1. Protein assembly and domain structure

The active biological assembly of LpxD is believed to be a trimer and the available three-dimensional structures from both E. coli (PDB entry 3eh0; Bartling & Raetz, 2009) and C. trachomatis (PDB entries 2iua, 2iu8 and 2iu9; Buetow et al., 2007) contain three protein copies in the crystal asymmetric unit. In the crystal structure from P. aeruginosa a comparable trimer is generated by crystallographic symmetry operators (Fig. 1).

Figure 1.

Figure 1

Orthogonal views of the trimeric biological assembly of LpxD from P. aeruginosa generated by the application of symmetry operators in the crystal. The three copies of the protein are colored purple, green and blue, respectively. These images were rendered using PyMOL (DeLano, 2002).

The characteristic LpxD domain architecture, consisting of an N-­terminal domain (amino acids 2–95), a left-handed β-helix central domain containing many short parallel β-sheet segments wrapping through consecutive triangular sections (amino acids 101–305) and a C-terminal helix (amino acids 312–340), is similar to that seen in the LpxD structures from E. coli and C. trachomatis. As might be anticipated from the interwoven network of stabilizing hydrogen bonds, the central domain is the most ordered region of the P. aeruginosa LpxD structure, with average B factors for main-chain/side-chain atoms of 10.8/13.1 Å2, compared with 14.7/16.5 Å2 for the N-terminal domain and 20.0/22.1 Å2 for the C-terminal helix.

Superpositions of the structure from P. aeruginosa onto apo crystal forms of LpxD from E. coli (PDB entry 3eh0) and C. trachomatis (PDB entry 2iua) using the Cα atoms in the central domain demonstrates a high degree of structure conservation in this region (Fig. 2). When Cα atoms from amino acids 101–305 in the present structure are independently superimposed onto equivalent atoms in the three copies of the E. coli protein the r.m.s. deviations between these sets of atoms are all ∼0.75 Å (Table 2). Similarly, when amino acids 101–189 and 193–305 (with the chain break being introduced to eliminate a dissimilar region around a point deletion in the C. trachomatis protein) are superimposed onto the three copies of the protein in the C. trachomatis crystal structure the r.m.s. deviations between equivalent Cα atoms are all ∼0.7 Å.

Figure 2.

Figure 2

Superposition of the structures of apo crystal forms of LpxD from E. coli (PDB entry 3eh0; blue ribbon) and C. trachomatis (PDB entry 2iua; red ribbon) onto the present structure from P. aeruginosa (yellow ribbon). The tag sequence in the structure from P. aeruginosa has been omitted from this figure.

Table 2. Structural comparisons of LpxD from P. aeruginosa with those from E. coli and C. trachomatis .

Independent overlays were performed using structurally related Cα atoms in the N-­terminal and central domains of the unique P. aeruginosa protein molecule with all three copies of the protein in the crystals of the E. coli and C. trachomatis proteins.

Species PDB entry Resolution (Å) R.m.s.d., N-terminal domain (Å) R.m.s.d., central domain (Å)
E. coli 3eh0 2.6 1.43, 1.38, 1.42 0.69, 0.74, 0.80
C. trachomatis 2iua 2.7 1.54, 1.05, 1.14 0.68, 0.67, 0.72

Some dissimilarity in the relative positions of the N-terminal domain and the central domain across species is apparent from the global comparisons outlined above (Fig. 2). In addition, an independent superposition of amino acids 5–95 from the P. aeruginosa structure onto the three structures from E. coli gives r.m.s. deviations between equivalent Cα atoms of ∼1.4 Å (Table 2), indicating that there are also somewhat greater differences within the N-terminal domain than within the central domain. Meaningful overlays of the N-terminal domain from P. aeruginosa onto the protein from C. trachomatis are complicated by the need to account for the shorter sequence for C. trachomatis owing to amino-acid deletions at multiple points; a limited overlay over amino acids equivalent to 5–60 gives r.m.s. deviations between equivalent Cα atoms of 1.1–1.5 Å, with the remainder of the structure in this domain containing regions of varying degrees of similarity across the deletion points.

The LpxD structures from E. coli and C. trachomatis differ in the connectivity of the C-terminal three-helix bundle that is formed from the trimeric assembly. The connectivity in the P. aeruginosa structure is the same as that in the E. coli structure (Fig. 2).

3.2. Ligand-binding sites

The P. aeruginosa LpxD crystal structure was solved without identifying the uridine diphosphate-N-acetylglucosamine (UDP-GlcNac) molecule that was contained in two of the crystal structures solved from C. trachomatis (PDB entries 2iu8 and 2iu9; Buetow et al., 2007). It does not appear likely that UDP-GlcNac binding is possible in this crystal form of the P. aeruginosa protein because the site is partially occluded by an N-terminal His tag (Fig. 3). The tag extends from a neighboring protein molecule (i.e. one that is not part of the LpxD trimer) in the crystal and winds through part of the UDP-GlcNac site. However, since the structures from C. trachomatis both with (PDB entries 2iu8 and 2iu9) and without (PDB entry 2iua) UDP-GlcNac indicate that there is only a minor change in the local conformation of one of the two proteins involved in UDP-GlcNac binding, this apo structure of P. aeruginosa LpxD is probably very similar to the UDP-GlcNac-bound form.

Figure 3.

Figure 3

Space-filling views of the region containing the N-terminal tag sequence in the structure from P. aeruginosa (right) and UDP-GlcNac binding in a structure from C. trachomatis (PDB entry 2iu8, left).

The available C. trachomatis LpxD structures also include several palmitic acid molecules bound within crevices between the central domains of the protein molecules in the trimer. Palmitic acid was not included in the crystallization conditions for our structure, but we have identified two bound diethylene glycol molecules in comparable regions, perhaps indicating the hydrophobic nature of this environment.

4. Conclusions

The structure of LpxD from P. aeruginosa has been solved at significantly higher resolution than other available LpxD structures in the PDB. This crystal structure may be stabilized by a 20-amino-acid N-terminal His tag, which includes 16 visible amino acids that interact with adjacent protein molecules in the crystal cell. The largest differences between this crystal structure and the previously known LpxD structures from E. coli and C. trachomatis are in the relative orientation of the central domain to the loosely connected C-­terminal domain and within the chain trace of the N-­terminal domain.

Supplementary Material

PDB reference: LpxD, 3pmo

Acknowledgments

The Berkeley Center for Structural Biology is supported in part by the National Institutes of Health, National Institute of General Medical Sciences and the Howard Hughes Medical Institute. The Advanced Light Source is supported by the Director, Office of Basic Energy Sciences of the US Department of Energy under Contract No. DE-AC02-05CH11231.

References

  1. Bartling, C. M. & Raetz, C. R. (2009). Biochemistry, 48, 8672–8683. [DOI] [PMC free article] [PubMed]
  2. Buetow, L., Smith, T. K., Dawson, A., Fyffe, S. & Hunter, W. N. (2007). Proc. Natl Acad. Sci. USA, 104, 4321–4326. [DOI] [PMC free article] [PubMed]
  3. DeLano, W. L. (2002). PyMOL http://www.pymol.org/.
  4. Esmon, C. T. (2000). Biochim. Biophys. Acta, 1477, 349–360. [DOI] [PubMed]
  5. Jacoby, G. A. (2005). Clin. Infect. Dis. 41, S120–S126.
  6. Kleywegt, G. J. & Jones, T. A. (1996). Structure, 4, 1395–1400. [DOI] [PubMed]
  7. Lockhart, S. R., Abramson, M. A., Beekmann, S. E., Gallagher, G., Riedel, S., Diekema, D. J., Quinn, J. P. & Doern, G. V. (2007). J. Clin. Microbiol. 45, 3352–3359. [DOI] [PMC free article] [PubMed]
  8. Lovell, S. C., Davis, I. W., Arendall, W. B., de Bakker, P. I., Word, J. M., Prisant, M. G., Richardson, J. S. & Richardson, D. C. (2003). Proteins, 50, 437–450. [DOI] [PubMed]
  9. Murshudov, G. N., Skubák, P., Lebedev, A. A., Pannu, N. S., Steiner, R. A., Nicholls, R. A., Winn, M. D., Long, F. & Vagin, A. A. (2011). Acta Cryst. D67, 355–367. [DOI] [PMC free article] [PubMed]
  10. Raetz, C. R. (1990). Annu. Rev. Biochem. 59, 129–170. [DOI] [PubMed]
  11. Raetz, C. R. & Whitfield, C. (2002). Annu. Rev. Biochem. 71, 635–700. [DOI] [PMC free article] [PubMed]
  12. Vagin, A. & Teplyakov, A. (2010). Acta Cryst. D66, 22–25. [DOI] [PubMed]
  13. Winn, M. D. et al. (2011). Acta Cryst. D67, 235–242.

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

PDB reference: LpxD, 3pmo


Articles from Acta Crystallographica Section F: Structural Biology and Crystallization Communications are provided here courtesy of International Union of Crystallography

RESOURCES